Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Merck
Chubb
US Army
Farmers Insurance
Deloitte

Generated: September 22, 2019

DrugPatentWatch Database Preview

Patent: 9,764,011

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,764,011
Title:Injection paradigm for administration of botulinum toxins
Abstract: Disorders such as headaches can be treated by administration of a botulinum toxin to a patient suffering therefrom, such as a migraine headache. A combined a fixed site/fixed dose and an optional follow the pain variable dosage and injection site paradigm is disclosed for optimizing clinical effectiveness of botulinum toxin administration for patients suffering headache, particularly chronic migraine.
Inventor(s): Turkel; Catherine C. (Newport Coast, CA), Aurora; Sheena K. (Seattle, WA), Brin; Mitchell F. (Newport Beach, CA)
Assignee: Allergan, Inc. (Irvine, CA)
Application Number:15/057,866
Patent Claims:see list of patent claims

Details for Patent 9,764,011

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Allergan BOTOX onabotulinumtoxina VIAL; SINGLE-USE 103000 001 1991-12-09   Try a Free Trial Allergan, Inc. (Irvine, CA) 2030-03-30 RX search
Allergan BOTOX onabotulinumtoxina VIAL; SINGLE-USE 103000 002 1991-12-09   Try a Free Trial Allergan, Inc. (Irvine, CA) 2030-03-30 RX search
Allergan BOTOX onabotulinumtoxina VIAL; SINGLE-USE 103000 003 1991-12-09   Try a Free Trial Allergan, Inc. (Irvine, CA) 2030-03-30 RX search
Allergan BOTOX COSMETIC onabotulinumtoxina VIAL; SINGLE-USE 103000 004 1991-12-09   Try a Free Trial Allergan, Inc. (Irvine, CA) 2030-03-30 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Harvard Business School
McKesson
Fish and Richardson
Colorcon
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.